Dhiraj Dhoot

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Atopic Dermatitis

Top Venues

Clinical, cosmetic and investigational dermatology

Infection and drug resistance

Dermatologic therapy

Psoriasis (Auckland, N.Z.)

This page only lists publications with an associated author ORCID identifier.

Publications

Bela Shah, Deval Mistry, Dharmender J, Kajal Kansara, Rutvi Pandya, Presha Vasani, Dhiraj Dhoot, Namrata Mahadkar, Sumit Bhushan, Hanmant Barkate
Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea. Infection and drug resistance 16 (2023)
Bela Shah, Deval Mistry, Nelry Gonsalves, Presha Vasani, Dhiraj Dhoot, Hanmant Barkate
A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris. Antibiotics (Basel, Switzerland) 12 (9) (2023)
Manjunath M Shenoy, Abhishek De, Bela Shah, Anupam Das, Abir Saraswat, Koushik Lahiri, Sheetal Yadav, Aarti Sarda, Disha Chakraborty, Dharmender J, Shruti Kamat, Yashika Doshi, Nelry Gonsalves, Ankita Choudhary, Dhiraj Dhoot, Namrata Mahadkar, Sumit Bhushan, Rujuta Gadkari, Hanmant Barkate
Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial. Drug design, development and therapy 17 (2023)
Bela Shah, Deval Mistry, Dharmender J, Kajal Kansara, Rutvi Pandya, Presha Vasani, Dhiraj Dhoot, Namrata Mahadkar, Sumit Bhushan, Hanmant Barkate
Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea. Infection and drug resistance 16 (2023)
Bela Shah, Dhiraj Dhoot, Ankita Choudhary, Neha Jangid, Deval Mistry, Shikha Shah, Shruti Kamat, Hanmant Barkate
A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria. Clinical, cosmetic and investigational dermatology 15 (2022)
Vishalakshi Viswanath, Pradnya Joshi, Mayuri Dhakne, Dhiraj Dhoot, Namrata Mahadkar, Hanmant Barkate
Evaluation of the Efficacy and Safety of Apremilast in the Management of Lichen Planus. Clinical, cosmetic and investigational dermatology 15 (2022)
Vishalakshi Viswanath, Pradnya Joshi, Prakash Lawate, Dakshata Tare, Dhiraj Dhoot, Namrata Mahadkar, Hanmant Barkate
An Open-Label, Randomized, Prospective, Comparative, Three-Arm Clinical Trial to Evaluate the Safety and Effectiveness of Apremilast with Three Different Titration Methods in Patients with Chronic Plaque Psoriasis in India. Psoriasis (Auckland, N.Z.) 12 (2022)
Manjunath Shenoy, Dhiraj Dhoot, Harshal Mahajan, Hanmant Barkate
An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India. Clinical, cosmetic and investigational dermatology 14 (2021)
Bela Shah, Abhishek De, Aarti Sarda, Atul M Kochhar, Dhiraj Dhoot, Gaurav Deshmukh, Hanmant Barkate
Effect of bilastine on chronic spontaneous urticaria refractory to levocetrizine: Real world experience in India. Dermatologic therapy 34 (1) (2020)